Fig. 4
From: The Janus-faced role of TRPM2-S in retroperitoneal liposarcoma via increasing ROS levels
TRPM2-S inhibits apoptosis via activating AKT. a–c Representative images of PI staining (a, b) and flow cytometry for apoptosis (c) (left panels), both two analyses showed that apoptosis rate was obviously increased in TRPM2-S-expressing RPLS cells (right panels). d Western blotting revealed that p-Akt, pP65, and Bcl-2 were upregulated in TRPM2-S-expressing RPLS cells compared with control cells